Standard BioTools Inc. develops and manufactures life science research tools based on mass cytometry and microfluidics technologies. Its CyTOF and Hyperion platforms enable high-parameter single-cell analysis and spatial tissue imaging for proteomics and genomics applications. The company supplies these systems, assays and services to researchers seeking detailed biological insights in translational and clinical settings.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 21.8 | — | -33.5 | — |
| Q3 2025 | 19.6 | — | -34.7 | — |
| Q4 2025 | 23.8 | — | 19.3 | — |
| Q1 2026 | 21.1 | — | 127.1 | — |
| Q2 2026 | 20.1 | -7.6% | -26.8 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Richardson Electronics, Ltd. (RELL), Vendome Acquisition Corporation I (VNME), Aurora Cannabis Inc. (ACB), Amtech Systems, Inc. (ASYS), Aviat Networks, Inc. (AVNW), Akebia Therapeutics, Inc. (AKBA)